Association between Hoehn and Yahr, Mini-Mental State Examination, age, and clinical syndrome predominance and diagnostic effectiveness of ioflupane I 123 injection (DaTSCANTM) in subjects with clinically uncertain parkinsonian syndromes-Reference-Cited by-同舟云学术

Association between Hoehn and Yahr, Mini-Mental State Examination, age, and clinical syndrome predominance and diagnostic effectiveness of ioflupane I 123 injection (DaTSCANTM) in subjects with clinically uncertain parkinsonian syndromes

Published:2014-10 Issue:5-8 Volume:6 Page:
ISSN:1758-9193
Container-title:Alzheimer's Research & Therapy
language:en
Short-container-title:Alz Res Therapy

Author:

Bajaj Nin,Hauser Robert A,Seibyl John,Kupsch Andreas,Plotkin Michail,Chen Chris,Grachev Igor D

Publisher

Springer Science and Business Media LLC

Subject

Cognitive Neuroscience,Neurology (clinical),Neurology

Link

http://link.springer.com/content/pdf/10.1186/s13195-014-0067-0.pdf

Reference20 articles.

1. Kupsch A, Bajaj A, Weiland F, Tartaglione A, Klutmann S, Buitendyk M, Paul Sherwin P, Ann Tate A, Grachev ID: Impact of DaTscanTM SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use, and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled study. J Neurol Neurosurg Psychiatry 2012, 83: 620-628. 10.1136/jnnp-2011-301695

2. Eusebio A, Azulay J-P, Ceccaldi M, Girard N, Mundler O, Guedj E: Voxel-based analysis of whole-brain effects of age and gender on dopamine transporter SPECT imaging in healthy subjects. Eur J Nucl Med Mol Imaging 2012, 39: 1778-1783. 10.1007/s00259-012-2207-8

3. Szewczyk-Krolikowski K, Tomlinson P, Nithi K, Talbot K, Ben-Shlomo Y, Hu MTM: The influence of age and gender on motor and non-motor features of early Parkinson’s disease: initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort. Parkinsonism Relat Disord 2014, 20B: 99-105. 10.1016/j.parkreldis.2013.09.025

4. Lang AE, Eberly S, Goetz , Stebbins G, Oakes D, Marek K, Ravina B, Tanner CM, Shoulson I: Movement Disorder Society Unified Parkinson Disease Rating Scale Experiences in Daily Living: longitudinal changes and correlation with other assessments. Mov Disord 2013, 28: 1980-1986. 10.1002/mds.25671

5. Nissen T, Malek N, Grosset KA, Newman J, Patterson J, Hadley D, Grosset DG: Baseline [123I]FP-CIT SPECT (DaTSCAN) severity correlates with medication use at 3 years in Parkinson’s disease. Acta Neurol Scand 2014, 129: 204-208. 10.1111/ane.12178

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker;Molecules;2022-05-10

2. Impact of age and sex correction on the diagnostic performance of dopamine transporter SPECT;European Journal of Nuclear Medicine and Molecular Imaging;2020-10-31

3. Brain FDG PET for the Etiological Diagnosis of Clinically Uncertain Cognitive Impairment During Delirium in Remission;Journal of Alzheimer's Disease;2020-10-13

4. Impairments in gait kinematics and postural control may not correlate with dopamine transporter depletion in individuals with mild to moderate Parkinson's disease;European Journal of Neuroscience;2019-01-29

5. [123I]Ioflupane imaging in Caucasians and non-Caucasians: Are there any differences?;Journal of the Neurological Sciences;2018-12